The gut-placental axis: microbial signals remodeling maternal-fetal immune tolerance
- 1Department of Obstetrics, Obstetrics and Gynecology Center, First Hospital of Jilin University
Abstract
Pregnancy represents a unique immunological challenge requiring the establishment and maintenance of maternal-fetal immune tolerance. Emerging evidence demonstrates that the gut microbiota serves as a critical regulator of placental immune responses through systemic immune remodeling, constituting what is now recognized as the gut-placental immune axis. This narrative review examines the molecular pathways through which intestinal signals reach the maternal-fetal interface, encompassing short-chain fatty acids, tryptophan derivatives and their aryl hydrocarbon receptor (AhR) ligands, secondary bile acids, microbe-associated molecular patterns, bacterial extracellular vesicles, and placental exosomes. These signals collectively regulate key immune cell populations, including myeloid-derived suppressor cells, regulatory T cell subsets such as RORγt ⁺ peripherally derived regulatory T cell (pTreg), Th17/Treg balance, macrophage polarization, and uterine natural killer (NK) cell function. We critically address the placental microbiome controversy, emphasizing that molecular signal transmission rather than live microbial colonization represents the prevailing paradigm for gut-placental communication. This paradigm shift redirects the research focus from identifying bacterial species to characterizing bioactive metabolites and microbe-associated molecular patterns. Furthermore, we elucidate how gut dysbiosis drives pathological cascades in major pregnancy complications, including preeclampsia, gestational diabetes mellitus, recurrent pregnancy loss, preterm birth, and fetal growth restriction. Finally, we evaluate clinical translation prospects encompassing probiotics, dietary fiber interventions, postbiotic metabolite supplementation, and engineered extracellular vesicle therapies, while acknowledging persistent challenges in establishing causal relationships, addressing individual heterogeneity, and ensuring long-term safety. This conceptual framework advances mechanistic understanding of microbiota-immune-placenta interactions and provides a foundation for developing microbiota-informed strategies to predict and prevent adverse pregnancy outcomes. Throughout, we explicitly distinguish human associative evidence from animal causal evidence.
Related
- Effects of Prepartum Flaxseed and Hermetia illucens Oil Supplementation on Fatty Acid Profiles Across the Maternal–Placental–Offspring Axis in Prolific Ewes
- Microbial Siderophores for Sustainable Agriculture: Stress Tolerance, Biocontrol, Mechanism, and Omics Integration
- Library strategies differentially shape microbial, functional, and host signals in clinical metagenomic sequencing
- Microbial metabolite-mediated gut–liver axis remodeling after hepatectomy: mechanisms and therapeutic opportunities
- Metabolically reprogrammed blastoids from totipotent-like stem cells exhibit enhanced tissue-specific organ-like development and placental formation
BibTeX
@article{shi2026gutplacental,
title = {{The gut-placental axis: microbial signals remodeling maternal-fetal immune tolerance}},
author = {Lin Shi and Yan Li and Yanxiang Mo},
journal = {Frontiers in Immunology},
year = {2026},
month = oct,
doi = {10.3389/fimmu.2026.1971075},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1971075/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - The gut-placental axis: microbial signals remodeling maternal-fetal immune tolerance
AU - Lin Shi
AU - Yan Li
AU - Yanxiang Mo
PY - 2026
DA - 2026/10/20
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.1971075
UR - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1971075/full
AB - Pregnancy represents a unique immunological challenge requiring the establishment and maintenance of maternal-fetal immune tolerance. Emerging evidence demonstrates that the gut microbiota serves as a critical regulator of placental immune responses through systemic immune remodeling, constituting what is now recognized as the gut-placental immune axis. This narrative review examines the molecular pathways through which intestinal signals reach the maternal-fetal interface, encompassing short-chain fatty acids, tryptophan derivatives and their aryl hydrocarbon receptor (AhR) ligands, secondary bile acids, microbe-associated molecular patterns, bacterial extracellular vesicles, and placental exosomes. These signals collectively regulate key immune cell populations, including myeloid-derived suppressor cells, regulatory T cell subsets such as RORγt ⁺ peripherally derived regulatory T cell (pTreg), Th17/Treg balance, macrophage polarization, and uterine natural killer (NK) cell function. We critically address the placental microbiome controversy, emphasizing that molecular signal transmission rather than live microbial colonization represents the prevailing paradigm for gut-placental communication. This paradigm shift redirects the research focus from identifying bacterial species to characterizing bioactive metabolites and microbe-associated molecular patterns. Furthermore, we elucidate how gut dysbiosis drives pathological cascades in major pregnancy complications, including preeclampsia, gestational diabetes mellitus, recurrent pregnancy loss, preterm birth, and fetal growth restriction. Finally, we evaluate clinical translation prospects encompassing probiotics, dietary fiber interventions, postbiotic metabolite supplementation, and engineered extracellular vesicle therapies, while acknowledging persistent challenges in establishing causal relationships, addressing individual heterogeneity, and ensuring long-term safety. This conceptual framework advances mechanistic understanding of microbiota-immune-placenta interactions and provides a foundation for developing microbiota-informed strategies to predict and prevent adverse pregnancy outcomes. Throughout, we explicitly distinguish human associative evidence from animal causal evidence.
SN - 1664-3224
ER -